Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Finch

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Kidney International|November 13, 2001
Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptorC S Ritter, J L Finch, E A Slatopolsky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1992
Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3J L Finch, A J Brown, T Mori, et al.
Kidney International|September 1, 1986
The effects of discontinuation of aluminum exposure on aluminum-induced osteomalaciaJ L Finch, M Bergfeld, K J Martin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 15, 2013
HPV-related cancers after solid organ transplantation in the United StatesM M Madeleine, J L Finch, C F Lynch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1997
A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor contentF Takahashi, J L Finch, M Denda, et al.
Kidney International|May 1, 1989
Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line UMR 106-01H C Blair, J L Finch, R Avioli, et al.
Kidney International. Supplement|September 1, 1990
New active analogues of vitamin D with low calcemic activityA J Brown, J L Finch, S Lopez-Hilker, et al.
International Journal of Cancer|March 17, 2000
Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel diseaseJ E Hardingham, P J Hewett, R E Sage, et al.
Cancer|June 15, 1980
Endometrial carcinoma: clinical-pathologic comparison of cases in postmenopausal women receiving and not receiving exogenous estrogensS G Silverberg, D Mullen, J A Faraci, et al.
The Journal of Clinical Investigation|September 1, 1989
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretionA J Brown, C R Ritter, J L Finch, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Kidney International|November 13, 2001
Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptorC S Ritter, J L Finch, E A Slatopolsky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1992
Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3J L Finch, A J Brown, T Mori, et al.
Kidney International|September 1, 1986
The effects of discontinuation of aluminum exposure on aluminum-induced osteomalaciaJ L Finch, M Bergfeld, K J Martin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 15, 2013
HPV-related cancers after solid organ transplantation in the United StatesM M Madeleine, J L Finch, C F Lynch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1997
A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor contentF Takahashi, J L Finch, M Denda, et al.
Kidney International|May 1, 1989
Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line UMR 106-01H C Blair, J L Finch, R Avioli, et al.
Kidney International. Supplement|September 1, 1990
New active analogues of vitamin D with low calcemic activityA J Brown, J L Finch, S Lopez-Hilker, et al.
International Journal of Cancer|March 17, 2000
Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel diseaseJ E Hardingham, P J Hewett, R E Sage, et al.
Cancer|June 15, 1980
Endometrial carcinoma: clinical-pathologic comparison of cases in postmenopausal women receiving and not receiving exogenous estrogensS G Silverberg, D Mullen, J A Faraci, et al.
The Journal of Clinical Investigation|September 1, 1989
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretionA J Brown, C R Ritter, J L Finch, et al.
Pageof 3